Global Healthcare, with endless capabilities
Accelerating the creation of every data-powered Healthcare application to become personalised, precise, and advanced
You are the fuel, by being able to contribute to the next generation of Smart Health applications and AI Networks.
Passively earn PHRM Coins from all applications that are listed on the network when they use your valuable data.
The catalyst to building super-intelligent Healthcare
A WORKING PRODUCT already in use
Interoperability in the value-transfer of data with PHRM Coins
Passively earn rewards for your valuable Medical Data
In the past two years alone, more than 90% of the entire world’s data was created. This is because of the increase in Smartphone and IoT usage.
We now collect more information than ever before, however the true benefit and potential of this is still new.
Pharmeum believes that in Healthcare, the value of this data is in building the future of Artificial Intelligence and mobile Health applications. These technologies feed on data, and the ability to access a large amount of it is difficult.
We can now incentivise the secure and private sharing of everyone’s data through PHRM Coins. While all users can trust the Blockchain to give them full rights and control over their valuable asset.
Medical Data is the most valuable data-type of all, and it is one of the few records collected throughout your entire life.
The soaring price is due to the potential the information holds. If it is controlled using Blockchain technology, then the applications are virtually unlimited.
Some of the potential of using Blockchain-based Medical Data include:
Our team combines both blockchain and healthcare experts to meet the demands of the project.
Besides being presented at Blockchain events all over the world, our focus has been to accomplish more than other projects, before the PHRM Token Sale.
Pharmeum already has a working product adopted and in use daily within the UK, one of the most strict healthcare industries. The Pharmeum Proof of Concept was live near August 2018, and the live blockchain MVP is successfully completed.
Pharmeum is focused on delivering results as opposed to being merely just a theory. Putting the project far ahead of all of its competition.
The inspiration is to accelerate the creation of super-intelligent Healthcare. This came from the realisation that data is the future. Some of the biggest companies in the world have already recognised the value of data. By using Blockchain technology we can allow users to control their data and be rewarded from it too.
This empowers everyone, even those in poorer countries, to profit from an asset that we all own.
Pharmeum is more focused on creation and traction, rather than just hype. The team have invested the past 2-3 years in building something that will become the final ingredient to advancing AI and Healthcare forever.
Data is the next big currency.
PHRM IEO tokens solve the issue within the interoperability of transferring and earning PHRM for data.
You can earn a digital token for your valuable data, and spend PHRM within real-world applications building on the network.
We believe that the dependency on data will grow over time. With this, the potential in your data will also grow. Pharmeum’s vision is to become the backbone of all digital Healthcare, Medicine and Pharma applications.
This will be a universe where users are at the centre. They control their data, earn crypto, and contribute to being a part of next-gen Healthcare globally.
Currently our main focus is development and partnerships. For these reasons, the Public Sale is not open yet.
The Public Sale will likely be in December 2019.
To give you the best chance to participate in the Public PHRM Token Sale, we recommend signing up on the waiting list and marking the ‘Welcome email’ as important.
The PHRM token sale will be carried out as an IEO, meaning that the public sale actually takes place on an exchange. Pharmeum is a unique project and many leading exchanges have shown interest in listing PHRM. The exact name of the exchange will be revealed closer to the Public Sale in December 2019.